Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Invention related to melanoma antigens available for licensing

Jan. 29, 1997

NIH seeks licensees for T-cell receptor technologies

Jan. 29, 1997

Water-soluble camptothecin analogue reported by SKB

Jan. 29, 1997

Clinical data on AccuSite published in peer-reviewed journals

Jan. 28, 1997

RPR discloses novel polypeptides for cancer

Jan. 28, 1997

Antibacterial and antineoplastic agents developed by Abbott

Jan. 28, 1997

Pharmacia & Upjohn claims camptothecin derivatives

Jan. 28, 1997

Promising findings reported for senescence genes

Jan. 27, 1997

Pharmos allowed patent for tamoxifen analogues

Jan. 27, 1997

Sagami reports novel antitumor agents

Jan. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...